12 Health Care Stocks Moving In Thursday's Intraday Session
Portfolio Pulse from Benzinga Insights
In Thursday's intraday session, several healthcare stocks experienced significant movements. Soligenix (SNGX) saw a dramatic increase of 249.1%, while Immunogen (IMGN) rose by 82.31%. Other gainers included Ampio Pharmaceuticals (AMPE), TransCode Therapeutics (RNAZ), LumiraDx (LMDX), and NeuBase Therapeutics (NBSE). Conversely, Vivos Therapeutics (VVOS) led the losers with a 40.5% drop, followed by declines in Altamira Therapeutics (CYTO), Redhill Biopharma (RDHL), Envoy Medical (COCH), ProSomnus (OSA), and ZyVersa Therapeutics (ZVSA).
November 30, 2023 | 5:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Ampio Pharmaceuticals' stock rose by 67.77% to $3.29, with a market value of $2.7 million.
Ampio Pharmaceuticals' significant stock price increase could be driven by positive news or market speculation, potentially leading to further short-term interest.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Immunogen shares increased by 82.31% to $29.28, with a market cap of $7.7 billion.
The significant rise in Immunogen's stock price indicates a highly positive development for the company, which could continue to attract investor attention in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
LumiraDx shares increased by 40.54% to $0.17, with a market value of $52.6 million.
LumiraDx's stock price growth indicates a positive market response, potentially due to favorable news or developments, which could impact the stock in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
NeuBase Therapeutics' stock rose by 27.39% to $0.82, with a market value of $3.0 million.
The increase in NeuBase Therapeutics' stock price could reflect positive investor sentiment or company progress, potentially influencing the stock's short-term trajectory.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
TransCode Therapeutics shares jumped by 44.64% to $0.36, with a market value of $7.2 million.
The notable increase in TransCode Therapeutics' shares could suggest positive investor sentiment or reactions to company-specific news, which may lead to short-term trading momentum.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Soligenix stock surged by 249.1% to $1.45, with a market cap of $15.0 million.
The substantial increase in stock price suggests a very positive market reaction, likely due to significant company news or developments. This could lead to increased investor interest and trading volume in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Envoy Medical stock decreased by 26.45% to $2.03, with a market value of $39.6 million.
Envoy Medical's stock price drop suggests a negative market reaction, possibly due to company-specific issues, which may affect the stock's short-term performance.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Altamira Therapeutics shares dropped by 39.49% to $0.39, with a market value of $3.1 million.
Altamira Therapeutics' significant stock price decrease could be due to adverse events or market reactions, likely leading to bearish sentiment in the short term.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
ProSomnus shares fell by 25.53% to $0.7, with a market value of $11.4 million.
The decrease in ProSomnus' stock price could be a result of negative investor sentiment or less favorable company prospects, impacting the stock in the short term.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Redhill Biopharma's stock declined by 36.46% to $1.83, with a market cap of $20.2 million.
The decline in Redhill Biopharma's stock price may reflect negative news or investor concerns, which could continue to impact the stock price in the short term.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Vivos Therapeutics stock fell by 40.5% to $24.38, with a market value of $29.1 million.
The sharp decline in Vivos Therapeutics' stock price suggests negative market sentiment or disappointing company news, which could continue to affect the stock negatively in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
ZyVersa Therapeutics shares declined by 23.89% to $0.07, with a market value of $3.1 million.
ZyVersa Therapeutics' stock price fall indicates potential negative developments or market sentiment, which could negatively influence the stock in the short term.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100